NOD2: Activation During Bacterial and Viral Infections, Polymorphisms and Potential as Therapeutic Target

Diana Alhelí Domínguez-Martínez1, Daniel Núñez-Avellaneda1, Carlos Alberto Castañón-Sánchez2

  • 1Laboratorio de Inmunología Celular e Inmunopatogénesis, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.

Insights

Nucleotide-binding domain (NBD) leucine-rich repeat (LRR)-containing receptors (NLRs), including NOD2, are crucial for detecting pathogens and maintaining tissue homeostasis. NOD2

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Nucleotide-binding domain (NBD) leucine-rich repeat (LRR)-containing receptors (NLRs) are cytoplasmic immune sensors.
  • NOD2, an NLR family member, dynamically interacts with proteins to modulate immune responses.
  • NOD2 plays roles in infection, tissue homeostasis, and inflammatory diseases.

Purpose of the Study:

  • To review the characteristics and importance of NOD2.
  • To discuss NOD2's role in bacterial and viral infections.
  • To examine NOD2's involvement in chronic inflammation and therapeutic potential.

Main Methods:

  • Literature review of experimental evidence and reports on NOD2.
  • Analysis of NOD2's interactions with effector proteins and other receptors.
  • Examination of NOD2 polymorphisms and their association with diseases.

Main Results:

  • NOD2 structural domains and effector protein interactions dictate anti-infective responses.
  • NOD2 is vital for immune responses against bacterial and viral pathogens.
  • NOD2 polymorphisms are linked to inflammatory diseases like Crohn's disease.

Conclusions:

  • NOD2 is a key regulator of innate immunity against infections.
  • NOD2's function extends to tissue homeostasis and inflammatory disease pathogenesis.
  • Targeting NOD2 presents potential therapeutic strategies for inflammatory conditions.

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
179
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Thermodynamics: Chemical Potential and Activity01:10

Thermodynamics: Chemical Potential and Activity

The effective concentration of a species in a solution can be expressed precisely in terms of its activity. Activity considers the effect of electrolytes present in the vicinity of the species of interest and depends on the ionic strength of the solution. The activity of a species is expressed as the product of molar concentration and the activity coefficient of the species.
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
1.8K
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
752